# CQY Capital

> CQY Capital is a VC fund in Shanghai backing Film and Mobile. See 6 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 6
- Last investment: Jun 2022
- Lead investor: 17%
- Last updated: Aug 2026
- Website: http://cqyfund.com/

CQY capital is a private equity investment fund management company.CQY's founding team is composed of five founding partner, founding partner of respectively from the real estate, health care, construction, finance, film and television executives and directors of the five industries, and there are three founding partners for three a-sharelisted company directors and actual controllers, including diving medical group vice chairman, gold mantis group director, sea silver's deputy chairman, WuNiu fund chairman, etc. CQY capital currently manages 5 billion yuan, mainly in the private equity business. Investment areas include healthcare, big health, culture and entertainment, TMT and fintech. CQY capital was established in August 2016. In the field of culture and entertainment, the company has invested in bona film, MOE books and lime film three large a-share pre-ipo projects. In the field of medical health, the company invests in Flycor Biomedical, the world's leading allergen detection equipment company. Meanwhile, a 3.17 billion yuan cinema acquisition fund was established in 2017. The core concept ofCQY capital is to gather all kinds of perseverance to create the most valuable fund for investors. In the future, the company will also expand diversified businesses such as securities investment, mezzanine investment, merger and acquisition fund and wealth management, and strive to become a new rising star in China's financial industry.

## Contacts

5 contacts available for CQY Capital. Shizune tracks 2 team members at CQY Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/cqy-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Film | 1 | 17% |
| Mobile | 1 | 17% |
| Content | 1 | 17% |
| Internet | 1 | 17% |
| Software | 1 | 17% |

15 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 2 | 33% |
| Seed | 1 | 17% |
| Series E | 1 | 17% |
| Private Equity | 1 | 17% |
| Venture - Series Unknown | 1 | 17% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 3 | 50% |
| United States | 1 | 17% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Zheng Wang | Founder, CEO & Partner | 0 | — |
| Wang Zheng | CEO, Partner | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| DeePoon | DeePoon VR develops head mounted devices as well as VR content. DeePoon’s technology is supported on both PC and mobile platforms. Its VR content distribution platform 3Dbobo has accumulated more than 1.5 million users, according to the company. The company’s valuation has now reached USD 830 million. They landed USD 30 million from downloadmanager Xunlei and mobile game developer Kingnet in Series B financing in December 2015. DeePoon will be able to use Xunlei’s technology in its content distribution network and cooperate with Kingnet to develop VR games. Animation and culture company Alpha also invested in the company and became its strategic partner at the end of last year to further collaborate in animation production, film production and game development. DeePoon’s main products include the Virglass series and E series VR helmets, which feature Active Matrix/Organic LED (AMOLED) display screens. |  | Venture - Series Unknown | Jun 17, 2022 |  |
| Zhongze Therapeutics | ZHONGZE Therapeutics is a clinical stage biotech company focused on the discovery, development and commercialization of innovative and transformative therapies for both psychiatric and neurological disorders. |  | Seed | Apr 21, 2022 |  |
| DeePoon | DeePoon VR develops head mounted devices as well as VR content. DeePoon’s technology is supported on both PC and mobile platforms. Its VR content distribution platform 3Dbobo has accumulated more than 1.5 million users, according to the company. The company’s valuation has now reached USD 830 million. They landed USD 30 million from downloadmanager Xunlei and mobile game developer Kingnet in Series B financing in December 2015. DeePoon will be able to use Xunlei’s technology in its content distribution network and cooperate with Kingnet to develop VR games. Animation and culture company Alpha also invested in the company and became its strategic partner at the end of last year to further collaborate in animation production, film production and game development. DeePoon’s main products include the Virglass series and E series VR helmets, which feature Active Matrix/Organic LED (AMOLED) display screens. |  | Series E | Nov 10, 2021 |  |
| MicroPort Orthopedics | MicroPort Orthopedics is a producer of orthopedic products and a member of the MicroPort Scientific Corporation family of companies. Its knee and hip implants are constantly being improved just as medical procedures. It operates as a start-up of an industry powerhouse. This is critical to achieving its goal of being the growing, innovation-drivencompany in orthopedics. Their top priority isn’t just to help surgeons get patients back to their feet. | $81.8M | Private Equity | May 13, 2020 |  |
| Linmon Pictures | Linmon Pictures is a boutique entertainment studio. Linmon Pictures is an independent creator, producer, and distributor of entertainment content. |  | Series C | Mar 12, 2018 |  |
| Motie.com | Motie.com is an online book publishing platform. | $42.5M | Series C | Jul 04, 2017 |  |

6 of 6 investments shown.

## Co-investors
- [Huaqiang Chuangtou](https://shizune.co/investors/profile/huaqiang-chuangtou) — VC Fund, 2 deals together
- [Five Bulls Fund](https://shizune.co/investors/profile/wuniu-capital) — VC Fund, 2 deals together
- [BOC & Utrust Private Equity Fund Management](https://shizune.co/investors/profile/boc-utrust-private-equity-fund-management) — VC Fund, 1 deal together
- [Cenova](https://shizune.co/investors/profile/cenova-ventures) — VC Fund, 1 deal together
- China Life Healthcare Fund — VC Fund, 1 deal together
- [CITIC Trust](https://shizune.co/investors/profile/citic-trust) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does CQY Capital invest in?

CQY Capital invests primarily in Film, Mobile and Content startups, most often at Series C and Seed stage. Most of the 6 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact CQY Capital?

Public channels for CQY Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at CQY Capital?

The team at CQY Capital includes Zheng Wang (Founder, CEO & Partner) and Wang Zheng (CEO, Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co